Columnists

Gad Gilad, PhD

Dr. Gad Gilad, the co-founder and CEO of Gilad&Gilad, LLC (www.ForNerveHealth.com), received his PhD in neurobiology and behavior from Cornell University. His research focus is the response of the nervous system to stress, neurotrauma and neurodegenerative diseases, and the development of new therapeutics. His collaboration with Varda H. Gilad while working at several academic centers, including the National Institutes of Health, Weizmann Institute of Science and Harvard University, resulted in more than 100 peer-reviewed scientific papers and several patents. One of their main discoveries is the neuroprotective properties of agmatine.

Previous Articles

A Nutraceutical for Neuropathies: Agmatine
March 1, 2018 (Vol. 36, Issue 03)